Tirzepatide represents a groundbreaking pharmaceutical agent for individuals facing type 2 diabetes. As a dual agonist, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic https://monicabyfv649583.bcbloggers.com/39416843/tirzepatide-a-game-changer-for-type-2-diabetes